PAR 1.67% 30.5¢ paradigm biopharmaceuticals limited..

Quote from the MST report " The MST valuation is risk adjusted...

  1. 339 Posts.
    lightbulb Created with Sketch. 129
    Quote from the MST report
    " The MST valuation is risk adjusted to reflect the probabilities of approval; 55% for KOA and 40.5% for MPs. Positive news of trial results and approval for the EU and US markets is likely to trigger ~ 2X in valuation for each indication."

    If the probabilities of approval alone for KOA is 55%, surely the value would be worth 10X more than the current estimate of $888m.

    So they are stating that its a bet where you have a 55% chance winning (approval) and having a future 10b+ business and they think its worth only $888m. I'd take those odds any day.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.005(1.67%)
Mkt cap ! $108.4M
Open High Low Value Volume
30.5¢ 31.5¢ 29.5¢ $152.7K 501.9K

Buyers (Bids)

No. Vol. Price($)
2 16864 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 20426 2
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.